Rovsing A/S Unveils Key Financial Dates for 2025 and 2026
Key Financial Milestones for Rovsing A/S in 2025 and 2026
Rovsing A/S, a well-regarded entity in its field, has outlined its financial calendar for the years 2025 and 2026. These upcoming dates are significant for investors and stakeholders who wish to stay informed about the company's performance and future direction.
Important Dates to Note
The following financial events have been scheduled:
Annual Report Release
Mark your calendars for 16 September 2025. This date celebrates the release of the Annual Report for the fiscal year 2024/25, offering insights into financial performance and strategic direction.
Annual General Meeting
On 21 October 2025, Rovsing A/S will hold its Annual General Meeting. This important gathering is open to shareholders and provides an opportunity to discuss the company's future and vote on core matters.
Quarterly Management Statements
Investors should pay attention to the Interim Management Statement for Q1 2025/26, which will be released on 11 November 2025. These statements offer a snapshot of the company's performance during the quarter.
Interim Reports
The Interim Report for the first half of 2025/26 will be released on 17 February 2026. This report is crucial for understanding how the year is progressing and the company's response to market conditions.
Continued Communication
In May 2026, Rovsing A/S will continue its commitment to transparency with the Interim Management Statement for Q3 2025/26, which is set for 12 May 2026. These statements are vital for keeping stakeholders informed.
Annual Reporting and Future Outlook
Investors will be eager to see how Rovsing A/S concludes this financial cycle. The Annual Report for 2025/26 will be published on 15 September 2026, followed by another Annual General Meeting on 20 October 2026. These events will provide a comprehensive review of the year and direction for the future.
Contact Information
For further inquiries, you can reach out to Sigurd Hundrup, CFO, at Tel. +45 53 39 18 92. For any electronic communication, feel free to contact via email at shu@rovsing.dk.
Frequently Asked Questions
What is the purpose of Rovsing A/S’s financial calendar?
The financial calendar provides key dates for important reports and meetings, helping stakeholders plan accordingly.
When is the Annual General Meeting for Rovsing A/S?
The Annual General Meeting is scheduled for 21 October 2025.
How can I obtain the Annual Report?
The Annual Report will be available on the company’s website or can be requested via their contact email.
Who is the contact person for investor relations?
Sigurd Hundrup, the CFO, is the contact person and can be reached by telephone or email.
When are the interim reports published?
The interim reports will be published on 11 November 2025 and 17 February 2026.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
